Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Christopher H. Polman
Clinical Effects of Natalizumab on Multiple Sclerosis Appear Early in Treatment Course
Journal of Neurology
Neurology
Related publications
Natalizumab Treatment in Multiple Sclerosis
Clinical Neurology
Neurology
Natalizumab Versus Fingolimod and Dimethyl Fumarate in Multiple Sclerosis Treatment
Annals of Clinical and Translational Neurology
Neuroscience
Neurology
Natalizumab: A New Treatment for Relapsing Remitting Multiple Sclerosis
Therapeutics and Clinical Risk Management
Chemical Health
Pharmacology
Safety
Medicine
Toxicology
Safety Research
Pharmaceutics
Efficacy of Natalizumab and Fingolimod in Relapsing Remitting Multiple Sclerosis in Real World Clinical Setting
Journal of Neurology & Neurophysiology
Impact of Mast Cells on Multiple Sclerosis: Inhibitory Effect of Natalizumab
International Journal of Immunopathology and Pharmacology
Allergy
Immunology
Pharmacology
Natalizumab Therapy for Highly Active Pediatric Multiple Sclerosis
JAMA Neurology
Neurology
Alemtuzumab Following Natalizumab in Highly Active Paediatric-Onset Multiple Sclerosis
Multiple Sclerosis Journal - Experimental, Translational and Clinical
Evolution of MRI Appearances Due to Progressive Multifocal Leucoencephalopathy Following Natalizumab Treatment for Multiple Sclerosis
BMJ Case Reports
Medicine
Intrathecal Effects of Daclizumab Treatment of Multiple Sclerosis
Neurology
Neurology